Key result
The overall yearly incidence rate of heart failure decreased by 3% per year (RR 0.97; 95% CI 0.96-0.97; P<0.0001), while prevalence steadily increased, particularly in those aged >85 years.
Why the study?
With improvements in cardiovascular prevention and life expectancy, trends in heart failure incidence and prevalence are dynamic and may differ over time by age and gender.
Observational (n=62,228)
Yes
Relative Risk: 0.97 (95% CI 0.96–0.97)
p-value: p=<0.0001
Despite a steady 3% annual decrease in heart failure incidence, the overall prevalence of the disease continues to rise, particularly among patients over 85 years of age.
May heighten HF care demands in octogenarians; leaves open drivers of diverging incidence-prevalence trends.
AIM: Heart failure (HF) is predominantly a disorder of the elderly. During the last decades, cardiovascular primary and secondary prevention and life expectancy have improved. Accordingly, trends in incidence and prevalence of HF are dynamic and may differ over time by age and gender. We aim to investigate the overall and age-specific and sex-specific trends, in incidence, prevalence, and the proportion with co-morbidities of HF over a 10 year period in Region Västra Götaland, Sweden. METHODS AND RESULTS: The VEGA database is an administrative database of all patients managed in hospital and/or in primary care (private and public) living in Region Västra Götaland. All patients with a main or contributory diagnosis of HF (I50) aged 18 years or older between 2008 and 2017 were included. Incidence and prevalence of HF were calculated based on the entire adult population of Region Västra Götaland. The adult population in Region Västra Götaland increased by 8% from 2008 (n = 1 234 609) to 2017 (n = 1 338 906). Half the population was female and 69% < 60 years of age, both constant over time. In total, 62 228 incident cases of HF were identified. In 2008, we identified 6464 cases, mean age 78.7 (11.5) years, and 49.8% (n = 3222) men, while in 2017, 5727 cases were identified, mean age 78.3 (11.8) years, and 52.5% (n = 3006) men. The overall yearly incidence rate of HF decreased by 3%, RR 0.97 (95% CI 0.96-0.97) per year, P < 0.0001, mainly driven by the age categories >75 years. A constantly higher incidence of HF was seen for men compared with women in all age categories, RR 1.46 (95% CI 1.44-1.49), P < 0.0001. During the same period, we observed a steady increase in overall prevalence from 1.8% for women and 2.0% for men in 2008, to 2.4% in women and 2.8% in men in 2017, particularly in those >85 years of age who had a prevalence of 16.5% (men) and 14.6% (women) in 2008 and 23.5% (men) and 21.5% (women) in 2017. The overall 1 year mortality rate was 22.7%. When adjusted for age, women had a lower risk for death by 13% compared with men [hazard ratio 0.87 (95% CI 0.84-0.90, P < 0.0001)]. CONCLUSION: We saw a decrease in overall incidence, but incidence of HF remains high, particularly in the oldest age groups. Prevalence of HF keeps increasing particularly in those aged >85 years. Our findings emphasize the need for implementation of effective preventive strategies for HF.
No takes yet. Share an insight, caveat, or question.
Wideqvist et al. (2022) conducted an observational in Heart failure (n=62,228). Time (per year) was evaluated on Yearly incidence rate of HF (RR 0.97, 95% CI 0.96-0.97, p=<0.0001). The overall yearly incidence rate of heart failure decreased by 3% per year (RR 0.97; 95% CI 0.96-0.97; P<0.0001), while prevalence steadily increased, particularly in those aged >85 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: